SMS Lifesciences India Ltd.(IN:HALEOSLABS)
₹1,650.90+60.90 (+3.83%)
IN:HALEOSLABS
SMS Lifesciences India Ltd. financials statements
₹1,650.90
At close:+60.90 (+3.83%)
Want to see IN:HALEOSLABS full AI Analyst Report?
SMS Lifesciences India Ltd. (HALEOSLABS) Ratios
1 Followers
SMS Lifesciences India Ltd. Ratios
IN:HALEOSLABS's free cash flow for Q3 2025 was ₹0.00. For the 2025 fiscal year, IN:HALEOSLABS's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.04 | 1.06 | 1.19 | 1.15 | 1.23 |
| Quick Ratio | 0.53 | 0.59 | 0.55 | 0.53 | 0.49 |
| Cash Ratio | 0.02 | 0.00 | 0.00 | 0.01 | 0.02 |
| Solvency Ratio | 0.15 | 0.20 | 0.11 | 0.18 | 0.13 |
| Operating Cash Flow Ratio | 0.22 | 0.24 | 0.00 | -0.08 | 0.17 |
| Short-Term Operating Cash Flow Coverage | 0.58 | 0.52 | 0.00 | -0.30 | 0.54 |
| Net Current Asset Value | ₹ -617.47M | ₹ -273.71M | ₹ -475.57M | ₹ -358.03M | ₹ -298.75M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.24 | 0.22 | 0.25 | 0.22 | 0.26 |
| Debt-to-Equity Ratio | 0.52 | 0.44 | 0.61 | 0.52 | 0.56 |
| Debt-to-Capital Ratio | 0.34 | 0.31 | 0.38 | 0.34 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.19 | 0.09 | 0.25 | 0.21 | 0.24 |
| Financial Leverage Ratio | 2.13 | 1.98 | 2.41 | 2.34 | 2.18 |
| Debt Service Coverage Ratio | 0.56 | 0.57 | 0.57 | 0.96 | 0.71 |
| Interest Coverage Ratio | 4.53 | 3.56 | 2.55 | 3.65 | 3.42 |
| Debt to Market Cap | 0.30 | 0.25 | 0.64 | 0.37 | 1.17 |
| Interest Debt Per Share | 386.98 | 313.78 | 354.86 | 283.70 | 230.62 |
| Net Debt to EBITDA | 2.42 | 1.73 | 2.94 | 1.61 | 2.31 |
| Profitability Margins | |||||
| Gross Profit Margin | 14.38% | 34.79% | 27.75% | 25.21% | 22.78% |
| EBIT Margin | 8.75% | 10.29% | 7.41% | 11.20% | 7.49% |
| EBITDA Margin | 13.38% | 14.74% | 10.83% | 14.08% | 10.55% |
| Operating Profit Margin | 8.75% | 8.95% | 5.49% | 6.49% | 6.85% |
| Pretax Profit Margin | 7.55% | 7.78% | 5.26% | 9.42% | 5.72% |
| Net Profit Margin | 5.19% | 5.97% | 3.63% | 7.29% | 3.97% |
| Continuous Operations Profit Margin | 5.33% | 5.56% | 3.61% | 7.28% | 3.97% |
| Net Income Per EBT | 68.71% | 76.78% | 69.08% | 77.36% | 69.42% |
| EBT Per EBIT | 86.26% | 86.93% | 95.70% | 145.22% | 83.44% |
| Return on Assets (ROA) | 3.81% | 5.16% | 2.90% | 7.10% | 4.03% |
| Return on Equity (ROE) | 8.11% | 10.23% | 6.99% | 16.63% | 8.80% |
| Return on Capital Employed (ROCE) | 9.80% | 12.15% | 6.63% | 10.18% | 10.60% |
| Return on Invested Capital (ROIC) | 5.77% | 6.86% | 4.96% | 6.73% | 6.33% |
| Return on Tangible Assets | 3.81% | 5.16% | 2.90% | 7.10% | 4.32% |
| Earnings Yield | 4.80% | 5.87% | 7.43% | 11.98% | 18.84% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.44 | 4.86 | 6.85 | 10.27 | 11.88 |
| Payables Turnover | 4.65 | 4.12 | 3.86 | 3.33 | 5.04 |
| Inventory Turnover | 3.58 | 3.26 | 2.64 | 3.06 | 3.08 |
| Fixed Asset Turnover | 1.20 | 1.43 | 2.25 | 1.80 | 2.09 |
| Asset Turnover | 0.73 | 0.86 | 0.80 | 0.97 | 1.02 |
| Working Capital Turnover Ratio | 43.54 | 35.05 | 13.68 | 20.88 | 13.75 |
| Cash Conversion Cycle | 90.60 | 98.53 | 96.67 | 45.28 | 76.77 |
| Days of Sales Outstanding | 67.07 | 75.05 | 53.28 | 35.56 | 30.73 |
| Days of Inventory Outstanding | 101.95 | 112.02 | 138.05 | 119.17 | 118.42 |
| Days of Payables Outstanding | 78.43 | 88.54 | 94.65 | 109.45 | 72.39 |
| Operating Cycle | 169.02 | 187.07 | 191.33 | 154.73 | 149.16 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 115.66 | 112.64 | 0.00 | -37.18 | 48.12 |
| Free Cash Flow Per Share | -75.74 | 61.87 | -0.00 | -206.38 | -29.13 |
| Dividend Paid and CapEx Coverage Ratio | 0.60 | 2.16 | 0.00 | -0.22 | 0.61 |
| Capital Expenditure Coverage Ratio | 0.60 | 2.22 | 0.30 | -0.22 | 0.62 |
| Operating Cash Flow Coverage Ratio | 0.32 | 0.39 | 0.00 | -0.14 | 0.23 |
| Operating Cash Flow to Sales Ratio | 0.10 | 0.10 | 0.00 | -0.03 | 0.06 |
| Free Cash Flow Yield | -6.34% | 5.46% | -0.00% | -29.51% | -16.30% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 20.85 | 17.03 | 13.45 | 8.35 | 5.31 |
| Price-to-Sales (P/S) Ratio | 1.08 | 1.02 | 0.49 | 0.61 | 0.21 |
| Price-to-Book (P/B) Ratio | 1.69 | 1.74 | 0.94 | 1.39 | 0.47 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.76 | 18.30 | -455547.28 | -3.39 | -6.14 |
| Price-to-Operating Cash Flow Ratio | 10.32 | 10.05 | 1049355.25 | -18.81 | 3.72 |
| Price-to-Earnings Growth (PEG) Ratio | -1.50 | 0.14 | -0.25 | 0.10 | -0.12 |
| Enterprise Value Multiple | 10.50 | 8.63 | 7.45 | 5.93 | 4.30 |
| Enterprise Value | 4.69B | 4.28B | 2.55B | 2.90B | 1.16B |
| EV to EBITDA | 10.50 | 8.63 | 7.45 | 5.93 | 4.30 |
| EV to Sales | 1.41 | 1.27 | 0.81 | 0.84 | 0.45 |
| EV to Free Cash Flow | -20.49 | 22.90 | -751968.25 | -4.65 | -13.23 |
| EV to Operating Cash Flow | 13.42 | 12.58 | 1732162.32 | -25.80 | 8.01 |
| Tangible Book Value Per Share | 759.27 | 701.21 | 622.31 | 545.15 | 326.14 |
| Shareholders’ Equity Per Share | 706.41 | 650.15 | 542.55 | 503.53 | 382.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.29 | 0.28 | 0.31 | 0.23 | 0.31 |
| Revenue Per Share | 1104.18 | 1113.96 | 1043.77 | 1148.76 | 848.83 |
| Net Income Per Share | 57.27 | 66.51 | 37.92 | 83.76 | 33.68 |
| Tax Burden | 0.69 | 0.77 | 0.69 | 0.77 | 0.69 |
| Interest Burden | 0.86 | 0.76 | 0.71 | 0.84 | 0.76 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.03 | 0.01 | 0.00 |
| SG&A to Revenue | 0.06 | 0.02 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.02 | 1.30 | 1.03 | -0.56 | 0.99 |
Currency in INR

